retatrutide vs vs. semaglutide: A head-to-head comparison Retatrutide vs CagriSema: The Battle

Briskin, M

PlexusDx maps 14 distinct metabolic pathways and 49 peptides through the Precision Peptide Genetic Test, identifying which pathways are driving your weight gain and which therapeutic targets are most likely to work for you personally

Mochi reports average first-year loss of 36 lbs and 4+ million cumulative pounds across patients

These are different products with different regulatory statuses, and the pricing, coverage, and clinical implications differ accordingly

The growing prevalence of chronic metabolic disorders in the United States indicates the need to evaluate antidiabetic treatments as strategies to both prevent incident dementia in people with T2D and to slow decline in people living with dementia with and without a T2D comorbidity

Months 46: Long-Term Success Patients who stay consistent often see significant changes in body composition and confidence